Discover the current challenges in diagnosing multiple myeloma and how advances in diagnostic technologies could help ...

Similarly, the CRAB criteria define organ damage caused by symptomatic multiple myeloma: C=Calcium: If the level in the blood exceeds 11.5 mg/dL, indicating hypercalcemia ...

The first sign of multiple myeloma varies by person and may not occur until a later stage of the disease. Learn how to ...

Multiple myeloma involves a comprehensive approach that combines blood tests, imaging, and bone marrow studies. Learn about ...

Landmark approval is based on results from the Phase 3 AQUILA study, showing fixed-duration treatment with daratumumab significantly reduced the risk of progression to active multiple myeloma or death ...

Teclistamab-cqyv is a T-cell-engaging bispecific antibody that targets multiple myeloma cells via the B-cell maturation antigen (BCMA) receptor. It received accelerated approval in 2022 for patients ...

Nearly all multiple myeloma patients are over age 45. Mr. Powell was 84. But it is rare, accounting for just 1.8 percent of cancers in the United States with 34,920 new cases a year, ...

The second-most common blood cancer in the U.S., multiple myeloma occurs twice as often and 5 to 10 years earlier among people who are African American as among those who are Caucasian.

Like treatments for many other cancers, treatments for multiple myeloma come with a high price. The drugs are “hideously expensive,” Dr. June said, costing more than $100,000 a year.